Not Signed In -
Alpha-1 Antitrypsin Deficiency |
AAT; alpha-1 proteinase inhibitor; alpha-1 related emphysema; genetic emphysema; hereditary pulmonary emphysema; inherited emphysema |
Clinical Trial: Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency
This study has been terminated.
|
Purpose
OBJECTIVES: I. Establish cell lines from patients with alpha 1-antitrypsin deficiency in order to examine genetic traits that predispose to liver injury.
| Condition |
|---|
| alpha 1-Antitrypsin Deficiency |
MedlinePlus related topics: Alpha-1 Antitrypsin Deficiency
Genetics Home Reference related topics: alpha-1 antitrypsin deficiency
Study Type: Observational
Study Design: Screening
Further Study Details:
Expected Total Enrollment: 160
Study start: March 1999
PROTOCOL OUTLINE: Patients undergo blood draw and skin biopsy. Cells are isolated from patients' blood and skin, cell lines are established, and genetic traits are examined.
Eligibility
Genders Eligible for Study: Both
Criteria
- Alpha 1-antitrypsin deficiency
Location Information
Pennsylvania
Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, 15213, United States
Study chairs or principal investigators
David H. Perlmutter, Study Chair, Children's Hospital of Pittsburgh
More Information
Study ID Numbers: 199/14810; WUSM-930603
Record last reviewed: May 2002
Last Updated: October 13, 2004
Record first received: April 6, 2000
ClinicalTrials.gov Identifier: NCT00005098
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: May 2002
Last Updated: October 13, 2004
Record first received: April 6, 2000
ClinicalTrials.gov Identifier: NCT00005098
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
